Artificial Intelligence-based
Praedigo addresses the significant burden of identifying patients with potential diseases by utilizing cutting-edge AI models that have been trained on the data of thousands of patients.
Half of the diabetes patients are estimated to develop diabetic polyneuropathy.¹
74% of adults over the age of 60 and 54% of adults over 40 are diagnosed with hypertension, which is a primary factor in the onset of more serious comorbidities.²
Our AI Models
Our machine learning models correctly identify 79% of DPN patients, while keeping the number of false diagnoses moderately low. In contrast, the current healthcare system only diagnoses up to 23%¹ of DPNs.
We also use our models to find important patterns and events that will help diagnose chronic disease comorbidities even further.
Improve the quality of life of diabetes patients
Support physicians in their decision-making and reduce time and cost efforts
Early identification of patients and simplified patient recruitment for clinical trials
Reduce costs for the healthcare system by earlier diagnosis of comorbidities
If you are interested in Praedigo we would be happy to discuss potential collaborations. Reach out to us.
References